Robert L. Stiller

Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States

Robert L. Stiller, John E. Bennett, H.J. Scholer et al. · Antimicrobial Agents and Chemotherapy · 1982 · 105 citations

Antifungal Agent, Antimicrobial Susceptibility, Health Sciences +12

Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis Model

Robert L. Stiller, John E. Bennett, H.J. Scholer et al. · The Journal of Infectious Diseases · 1983 · 100 citations

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

David A. Stevens, Robert L. Stiller, Paul L. Williams et al. · The American Journal of Medicine · 1983 · 65 citations

Diagnostic Mycology, Antifungal Agent, Progressive Coccidioidomycosis +3

Analysis of Candida albicans phenotypes from different geographical and anatomical sources

Frank C. Odds, A.B. Abbott, Robert L. Stiller et al. · Journal of Clinical Microbiology · 1983 · 64 citations · Full text

Diagnostic Mycology, Fungal Pathogen, Candida Albicans +13

Increased Intrapulmonary Retention of Radiolabeled Neutrophils in Early Oxygen Toxicity

Jean E. Rinaldo, Dallas R. English, Joel S. Levine et al. · American Review of Respiratory Disease · 1988 · 43 citations

Acute Lung Injury, Early Oxygen Toxicity, Lung Inflammation +18